DSM and Rostekhnologii to cooperate on biotechnology and functional materials

DSM and Rostekhnologii to cooperate on biotechnology and functional materials 
HEERLEN, NETHERLANDS -- (Marketwired) -- 04/08/13 --  
Royal DSM, the global Life Sciences and Materials Sciences company,
today that it has signed a Memorandum of Understanding
(MOU) for a strategic
partnership with Rostekhnologii (Rostec), a
Russian State Corporation, in the
fields of biotechnology and
functional materials. The MOU was signed today in
(Netherlands) in the presence of President Vladimir Putin of the
Russian Federation and Prime Minister Mark Rutte of the Netherlands. 
Under the terms of the MOU, DSM and Rostec will explore a potential
in the field of conversion of cellulosic biomass from
forestry and agriculture
to fermentable sugars for the production of
biofuels and/or biobased chemicals
as well as the manufacturing of
bio-based products such as bioethanol, biogas
and organic acids from
sugars derived from cellulosic biomass. 
DSM and Rostec will also explore to cooperate in the area of
enhancing the performance of Russia's fast expanding optical fiber
networks using DSM's UV-curable resins optical fiber materials. In
addition, DSM Dyneema and RT- Chemcomposite, part of Rostec, will
investigate the establishment of a joint
venture for the production
and sales of Uni-Directional products based on Ultra
High Molecular
Weight PE-fibers in Russia using DSM's proprietary technology for
life protection applications. 
Vladimir Artyakov, Deputy CEO of Rostekhnologii, said: "The
cooperation with DSM will accelerate the process of introducing new,
unique products in the Russian
market to be used in different areas,
including biotechnology and functional
materials. The partnership
with DSM is strategic and intended for the long term." 
Feike Sijbesma, Chief Executive Officer and Chairman of the DSM
Managing Board,
said: "As 2013 was declared a year of friendship
between the Netherlands and
Russia, this is a perfect occasion to
explore opportunities for further cooperation between DSM and Russia.
With two joint ventures already in place, I am looking forward to a
successful cooperation in several important business
areas including
the development of advanced biofuels with Rostec." 
For DSM, Russia is one of the High Growth Economies the company is
focusing on
in executing its strategy DSM in motion: driving focused
growth. DSM's main business areas in Russia are food and feed
ingredients, pharmaceutical intermediate products, biotechnology,
fiber materials, resins and engineering
plastics. Through its
business activities, DSM meets the needs and trends in the Russian
Federation, including localization (import substitution),
in technologies and diversification (less oil
dependence). In 2012, DSM celebrated 20 years of presence in Russia. 
In 2010 DSM started a joint venture in Tatarstan to contribute to
Russia's goal
of reaching a higher self-sufficiency in animal protein
production and supply by securing better animal nutrition. In 2011
DSM entered into a long-term partnership in the area of engineering
plastics with JSC KuibyshevAzot in Tolyatti (Samara Region) in order
to supply locally produced products to the
automotive and electrical
& electronics industries. 
State Corporation Russian Technologies (Rostec) is a Russian
corporation established in 2007 in order to facilitate the
development, manufacturing and
export of high-technology industrial
products. Today it comprises about 663 companies with activities
ranging from automotive to aviation, building, electronics,
telecommunications and defense technology. Rostec's subsidiaries
located in 60 regions of the Russian Federation and supply their
products to over 70 countries worldwide. In 2012 net sales amounted
to RUB 963 billion (~EUR
24 billion) with more than 900,000
DSM - Bright Science. Brighter Living.(TM) 
Royal DSM is a global science-based company active in health,
nutrition and materials. By connecting its unique competences in Life
Sciences and Materials
Sciences DSM is driving economic prosperity,
environmental progress and social
advances to create sustainable
value for all stakeholders. DSM delivers innovative solutions that
nourish, protect and improve performance in global
markets such as
food and dietary supplements, personal care, feed, pharmaceuticals,
medical devices, automotive, paints, electrical and electronics, life
protection, alternative energy and bio-based materials. DSM's
employees deliver annual net sales of around EUR9 billion. The
company is listed on NYSE Euronext. More information can be found at
Press release-pdf: http://hugin.info/130663/R/1691212/555338.pdf 
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants
(i) the releases contained herein are protected by copyright and    
other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and     
originality of the information contained therein. 
Source: DSM N.V.  via Thomson Reuters ONE 
For more information:
DSM Corporate Communications
Herman Betten
tel. +31 (0) 45 5782017
e-mail media.relations@dsm.com 
DSM Investor Relations
Dave Huizing
tel. +31 (0) 45 5782864
e-mail investor.relations@dsm.com 
Antonina Gribanova
Tel. +7 (967) 053 85 68
e-mail agribanova@apostolmedia.ru 
Yulia Lebedinskaya
Tel. +7 (967) 053 72 15
e-mail yulebedinskaya@apostolmedia.ru
Press spacebar to pause and continue. Press esc to stop.